Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Debt / NOTE 3.000% 8/1
-
Market price (% of par)
-
128.83%
-
Total 13F principal
-
$158,031,370
-
Principal change
-
$0
-
Total reported market value
-
$212,822,000
-
Number of holders
-
17
-
Value change
-
+$490,292
-
Number of buys
-
1
-
Number of sells
-
2
Institutional Holders of PTC THERAPEUTICS INC - NOTE 3.000% 8/1 as of Q4 2020
As of 31 Dec 2020,
PTC THERAPEUTICS INC - NOTE 3.000% 8/1 was held by
17 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$158,031,370
in principal (par value) of the bond.
The largest 10 bondholders included
DeepCurrents Investment Group LLC, D. E. Shaw & Co., Inc., WOLVERINE ASSET MANAGEMENT LLC, LAZARD ASSET MANAGEMENT LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), TENOR CAPITAL MANAGEMENT Co., L.P., Opti Capital Management, LP, Verition Fund Management LLC, CSS LLC/IL, and Allianz Asset Management GmbH.
This page lists
17
institutional bondholders reporting positions
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.